Image Source: DepositPhotos

We sat down with Joel Fruendt, CEO of SNES (SenesTech), for an exclusive deep-dive into the $4B rodent control market and the company’s game-changing product Evolve – a revolutionary form of rodent birth control.

• Why tariffs are NOT impacting their business and what that means for growth
• Urban expansion into NYC and now San Francisco
• Momentum building with retail rollouts and field adoption
• A forward-looking roadmap of potential catalysts and opportunities ahead

Now available on AMZN, WMT, & TSCO.

This could be a game-changer for their urban deployment strategy.

Video Length: 00:26:57

Related Articles:
SenesTech: A Little-Known Biotech Company Worthy Of Attention
SenesTech: The Smart Money’s Bet On Rodent Population Control
SenesTech Has Built A Better Mouse Trap

More By This Author:

SenesTech CEO Interview: Breaking Down Record Earnings & The Road To Profitability
Stock Market Outlook: Key Levels, Short Squeeze Plays And Trade Setups
Will The Market Hold? QQQ’s Critical Test & Top Trade Ideas